• Medycyna
  • 29 kwietnia
  • FDA to approve AstraZeneca's Truqap (capivasertib)
    2
  • 30 grudnia
  • CDC to issue Level 3 warning by December 31
    2
  • CDC to issue Level 4 warning by December 31
    2
  • FDA approves Retatrutide this year?
    2